← All Investors
ROCKET PHARMACEUTICALS INC
RCKTW
Holders
1
Combined Value
$6.5K
Combined Shares
309,997
Current Price
$0.01
52W High
$0.01
vs 52W High
−1.1%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $6.5K | 0.00% | ~$0.06 | −84.4% | Sold Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | SELL | −$31 | ~$0.02 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SELL | −$25 | ~$0.02 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SELL | −$73 | ~$0.04 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SELL | −$70 | ~$0.03 |
| Q1 2025 | Ken Griffin - Citadel Advisors | SELL | −$954 | ~$0.05 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SELL | −$198 | ~$0.03 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SELL | −$1.9K | ~$0.07 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$22K | ~$0.06 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 1 | 309,997 | −0.5% | $6.5K | $0.02 |
| Q4 2025 | 1 | 311,489 | −0.4% | $6.2K | $0.02 |
| Q3 2025 | 1 | 312,789 | −0.7% | $11K | $0.04 |
| Q2 2025 | 1 | 314,842 | −0.8% | $9.1K | $0.03 |
| Q1 2025 | 1 | 317,303 | −6.0% | $14K | $0.05 |
| Q4 2024 | 1 | 337,604 | −1.7% | $11K | $0.03 |
| Q3 2024 | 1 | 343,397 | −7.3% | $24K | $0.07 |
| Q2 2024 | 1 | 370,599 | — | $22K | $0.06 |